Author Description

This text, containing contributions from an international team of experts in chronic myeloid leukaemia, examines the advances being made in our understanding of this disease, and the implications these have for its management. Topics covered include a review of molecular and cellular biology, discussion of conventional chemotherapy and interferon therapy, and recent developments in allografting and autografting.